Development of a Telemedical Network Supporting an Automated Flow Cytometric Analysis for the Clinical Follow-up of Leukaemia

Main Authors: Claude Takenga, Rolf-Dietrich Berndt, Erling Si, Markus Diem, Guohui Qiao, Melanie Gau, Michael Brandstoetter, Martin Kampel, Michael Dworzak
Format: Article Journal
Bahasa: eng
Terbitan: , 2016
Subjects:
Online Access: https://zenodo.org/record/1127082
ctrlnum 1127082
fullrecord <?xml version="1.0"?> <dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><creator>Claude Takenga</creator><creator>Rolf-Dietrich Berndt</creator><creator>Erling Si</creator><creator>Markus Diem</creator><creator>Guohui Qiao</creator><creator>Melanie Gau</creator><creator>Michael Brandstoetter</creator><creator>Martin Kampel</creator><creator>Michael Dworzak</creator><date>2016-09-01</date><description>In patients with acute lymphoblastic leukaemia (ALL), treatment response is increasingly evaluated with minimal residual disease (MRD) analyses. Flow Cytometry (FCM) is a fast and sensitive method to detect MRD. However, the interpretation of these multi-parametric data requires intensive operator training and experience. This paper presents a pipeline-software, as a ready-to-use FCM-based MRD-assessment tool for the daily clinical practice for patients with ALL. The new tool increases accuracy in assessment of FCM-MRD in samples which are difficult to analyse by conventional operator-based gating since computer-aided analysis potentially has a superior resolution due to utilization of the whole multi-parametric FCM-data space at once instead of step-wise, two-dimensional plot-based visualization. The system developed as a telemedical network reduces the work-load and lab-costs, staff-time needed for training, continuous quality control, operator-based data interpretation. It allows dissemination of automated FCM-MRD analysis to medical centres which have no established expertise for the benefit of an even larger community of diseased children worldwide. We established a telemedical network system for analysis and clinical follow-up and treatment monitoring of Leukaemia. The system is scalable and adapted to link several centres and laboratories worldwide.</description><identifier>https://zenodo.org/record/1127082</identifier><identifier>10.5281/zenodo.1127082</identifier><identifier>oai:zenodo.org:1127082</identifier><language>eng</language><relation>doi:10.5281/zenodo.1127081</relation><relation>url:https://zenodo.org/communities/waset</relation><rights>info:eu-repo/semantics/openAccess</rights><rights>https://creativecommons.org/licenses/by/4.0/legalcode</rights><subject>Data security</subject><subject>flow cytometry</subject><subject>leukaemia</subject><subject>telematics platform</subject><subject>telemedicine.</subject><title>Development of a Telemedical Network Supporting an Automated Flow Cytometric Analysis for the Clinical Follow-up of Leukaemia</title><type>Journal:Article</type><type>Journal:Article</type><recordID>1127082</recordID></dc>
language eng
format Journal:Article
Journal
Journal:Journal
author Claude Takenga
Rolf-Dietrich Berndt
Erling Si
Markus Diem
Guohui Qiao
Melanie Gau
Michael Brandstoetter
Martin Kampel
Michael Dworzak
title Development of a Telemedical Network Supporting an Automated Flow Cytometric Analysis for the Clinical Follow-up of Leukaemia
publishDate 2016
topic Data security
flow cytometry
leukaemia
telematics platform
telemedicine
url https://zenodo.org/record/1127082
contents In patients with acute lymphoblastic leukaemia (ALL), treatment response is increasingly evaluated with minimal residual disease (MRD) analyses. Flow Cytometry (FCM) is a fast and sensitive method to detect MRD. However, the interpretation of these multi-parametric data requires intensive operator training and experience. This paper presents a pipeline-software, as a ready-to-use FCM-based MRD-assessment tool for the daily clinical practice for patients with ALL. The new tool increases accuracy in assessment of FCM-MRD in samples which are difficult to analyse by conventional operator-based gating since computer-aided analysis potentially has a superior resolution due to utilization of the whole multi-parametric FCM-data space at once instead of step-wise, two-dimensional plot-based visualization. The system developed as a telemedical network reduces the work-load and lab-costs, staff-time needed for training, continuous quality control, operator-based data interpretation. It allows dissemination of automated FCM-MRD analysis to medical centres which have no established expertise for the benefit of an even larger community of diseased children worldwide. We established a telemedical network system for analysis and clinical follow-up and treatment monitoring of Leukaemia. The system is scalable and adapted to link several centres and laboratories worldwide.
id IOS16997.1127082
institution ZAIN Publications
institution_id 7213
institution_type library:special
library
library Cognizance Journal of Multidisciplinary Studies
library_id 5267
collection Cognizance Journal of Multidisciplinary Studies
repository_id 16997
subject_area Multidisciplinary
city Stockholm
province INTERNASIONAL
shared_to_ipusnas_str 1
repoId IOS16997
first_indexed 2022-06-06T03:37:04Z
last_indexed 2022-06-06T03:37:04Z
recordtype dc
_version_ 1734899194652524544
score 17.538404